125 related articles for article (PubMed ID: 37948488)
21. High Serum Neuron-Specific Enolase (NSE) Level Firstly Ignored as Normal Reaction in a Small Cell Lung Cancer Patient: a Case Report and Literature Review.
Ge YL; Liu CH; Wang MH; Zhu XY; Zhang Q; Li ZZ; Li HL; Cui ZY; Zhang HF; Zhang X; Yu HL; Fu AS; Wang HY
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775876
[TBL] [Abstract][Full Text] [Related]
22. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
[TBL] [Abstract][Full Text] [Related]
23. Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer.
Quoix E; Charloux A; Popin E; Pauli G
Eur J Cancer; 1993; 29A(16):2248-50. PubMed ID: 8110494
[TBL] [Abstract][Full Text] [Related]
24. Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis.
Li H; Liu L; Zhou W; Rui Y; He B; Shi Y; Su X
Clin Microbiol Infect; 2019 Apr; 25(4):504-510. PubMed ID: 29964232
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
26. Detection of
Ye F; Zeng P; Li Z; Tang C; Liu W; Su D; Zhan Y; Li S
Ann Clin Lab Sci; 2021 Sep; 51(5):698-704. PubMed ID: 34686513
[TBL] [Abstract][Full Text] [Related]
27. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952
[No Abstract] [Full Text] [Related]
28. [Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
Mori Y; Hoshi H; Jinnouchi S; Harada K; Onoe K; Nagamachi S; Ozawa M; Watanabe K; Tawara Y
Radioisotopes; 1987 Feb; 36(2):78-80. PubMed ID: 3033753
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
Yumoto Y; Shiota T; Tamai M; Okabe K; Kiura K; Shimoe T; Fujii M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2089-93. PubMed ID: 3013098
[TBL] [Abstract][Full Text] [Related]
30. Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseases.
Collazos J; Esteban C; Fernández A; Genollá J
Am J Respir Crit Care Med; 1994 Jul; 150(1):143-5. PubMed ID: 8025740
[TBL] [Abstract][Full Text] [Related]
31. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer.
Wang H; Zhang X; Liu X; Liu K; Li Y; Xu H
J Cancer Res Ther; 2016; 12(1):355-8. PubMed ID: 27072263
[TBL] [Abstract][Full Text] [Related]
33. Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer.
Bi H; Yin L; Fang W; Song S; Wu S; Shen J
Lab Med; 2023 Jul; 54(4):372-379. PubMed ID: 36282321
[TBL] [Abstract][Full Text] [Related]
34. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
Li J; Chen P; Mao CM; Tang XP; Zhu LR
Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis.
Lai G; Zeng C; Mo J; Song WD; Xu P
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31941687
[TBL] [Abstract][Full Text] [Related]
37. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.
Izumikawa K; Yamamoto Y; Mihara T; Takazono T; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yanagihara K; Mine M; Yasuoka A; Tashiro T; Kohno S
Med Mycol; 2012 Nov; 50(8):811-7. PubMed ID: 22568603
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of serum neuron-specific enolase in non-small cell lung cancer].
Kimura H; Yamaguchi T; Nishino K; Nakagawa M; Yokota S; Nishikawa H; Ito M; Ogura T
Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):128-32. PubMed ID: 9617138
[TBL] [Abstract][Full Text] [Related]
39. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
[TBL] [Abstract][Full Text] [Related]
40. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
